|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
ABSTRACT |
|---|
|
|
|---|
Convincing evidence now exists that particulate air pollution exacerbates heart and lung disease, leading to increased morbidity and mortality. The populations particularly susceptible to these exposures are still unclear. Recent work on potential mechanisms of action of particulate air pollution point to pathways also influenced by diabetes. We examined whether diabetes modified the effect of airborne particles by looking at the association of PM10 with hospital admissions for heart and lung disease in persons with or without diabetes as a comorbidity. In addition we stratified by age within persons with and without diabetes. We used Medicare data for Cook County, Illinois for the years 1988-1994, and found that a 10 µg/m3 increase in PM10 was associated with a 2.01% (95% CI 1.40-2.62%) increase in admissions for heart disease with diabetes, but only a 0.94% (95% CI 0.61-1.28%) increase in persons without diabetes. Similar effect modification was not seen for lung diseases. When analyzing by age we found twice the PM10-associated risk for heart disease in diabetics than nondiabetics in both age groups. We found for pneumonia admissions that diabetes is an effect modifier in the younger age group, and for COPD in the older age group. We conclude that persons with diabetes are a susceptible population.
Keywords: particles; diabetes; air pollution; heart disease; PM10
| |
INTRODUCTION |
|---|
|
|
|---|
Particulate air pollution has been associated with increases in daily deaths and hospital admissions in dozens of studies across the world (1, 2). Recent studies have shown that these associations are not confounded by gaseous copollutants (3), seasonal patterns, or weather (5, 6). These results indicate that the associations should be considered as causal. However, it is unclear which populations are particularly susceptible to the adverse effects of particulate matter with aerodynamic diameter < 10 µm (PM10), and this has been identified as a key research need (7).
We previously examined race, sex, and socioeconomic status as modifiers of the effect of air pollution on mortality (8), and found little evidence of substantial modification. Similarly weak patterns were found for hospital admissions (4, 9). In contrast, preexisting chronic obstructive pulmonary disease (COPD) has been reported as an important effect modifier for mortality (10).
In recent studies, exposure to airborne particles has been associated with reduced heart rate variability (11, 12), increased C reactive protein (13) concentrations, and higher peripheral white cell counts (14) and fibrinogen levels (15). Diabetes is a chronic disease characterized by disturbances in all of these cardiovascular risk factors (16), and we hypothesized that diabetics might therefore be at increased risk of PM10-associated cardiovascular events. In contrast, although PM10 has a larger percentage impact on respiratory hospital admissions (4), it seems less likely that those risks would be modified by diabetes. To test these hypotheses, we used hospital discharge data available from the Health Care Financing Administration and examined admissions for heart and lung disease. These data were then stratified by whether diabetes was present as a comorbidity and analyzed to look at effect modification by concurrent diagnosis of diabetes.
In our previous study on Chicago (9) we did not find that sex, age, and race were modifiers of the effect of PM10 on hospital admissions for heart and lung disease, so these factors should not modify the associations that we found for diabetes. However we decided to stratify by diabetes and age, as this was the factor that showed a weak indication of effect modification. This study was approved by the Harvard School of Public Health Institutional Review Board.
| |
METHODS |
|---|
|
|
|---|
Health Data
The health data were extracted from the Health Care Financing Administration (MEDICARE) billing records, which provides hospital coverage for all U.S. citizens aged 65 and over. We analyzed data from Cook County, Illinois, between 1988 and 1994. Cook County was chosen because it is the most populous county in the United States with daily PM10 monitoring. We computed daily counts of hospital admissions for cardiovascular disease (International Classification of Disease, ICD-9: 390-429), pneumonia (ICD-9: 480-487), and COPD (ICD-9: 490-496, excluding 493). We stratified these counts into admissions with or without a notation of diabetes (ICD-9 250) as a secondary, contributing factor for the admission. We also stratified by age: subjects with and without diabetes were divided into subjects 75 yr and younger and older than 75 yr.
The association between these daily counts and PM10 was examined for the years 1988-1994, when daily PM10 monitoring data were available in Chicago.
If diabetes modified the effect of particulate matter on the cardiovascular health of persons with underlying heart disease, then the risk of a hospital admission for heart disease might be different in persons with diabetes. If this were true, then the risk ratio of a 10 µg/m3 increase of PM10 on cardiovascular admissions of persons with concurrent diabetes would be different from the ratio in persons without diabetes.
Weather data for O'Hare Airport were obtained from the EarthInfo CD ROM (EarthInfo CD NCDC Surface Airways, EarthInfo Inc., Boulder, CO), and air pollution data were obtained from the U.S. Environmental Protection Agency's Aerometric Information Retrieval System (AIRS) network (19). The daily values for PM10 were computed as the average of 10 monitors, two of which measured PM10 almost every day and the others less frequently.
Methods
The associations between hospital admission counts and PM10 were investigated with a generalized additive robust Poisson regression model (20). This approach has become the norm in such studies (21- 23) and the results for the association between hospital admissions in Chicago and PM10 (without stratification by diabetes status) have already been published (4). The generalized additive model uses nonparametric smooth functions to estimate the relation between the outcome and each predictor. This allows us to better model the nonlinear dependence of daily admissions on weather and season. The covariates we examined were temperature, prior day's temperature, relative humidity, barometric pressure, and day of week.
To control for weather variables and day of the week, we chose the smoothing parameter that minimized the Akaike's Information Criterion (24). To model seasonality we chose the smoothing parameter that minimized the sum of the autocorrelation of the residuals while removing seasonal patterns. Two autoregressive terms (25) were added in the model to eliminate the remaining serial correlation from the residuals. The mean of PM10 on the day of the admission and the day before the admission was used as our exposure variable and was treated linearly. Further details have been published previously (4).
We considered effect modification to be indicated when the estimates of PM10 in the group with diabetes were outside of the 95% confidence interval of the effect estimate in persons without diabetes.
| |
RESULTS |
|---|
|
|
|---|
Table 1 shows the minimum, mean, and maximum values of daily admissions for COPD, cardiovascular disease (CVD), and pneumonia with and without a concurrent diagnosis of diabetes and by diabetes and age group. Admissions for pneumonia and COPD without diabetes were seven to eight times as common as admissions for those causes with diabetes. For heart disease, the ratio was only 4 to 1, reflecting the tighter association of diabetes with heart disease.
|
Table 2 shows the 25, 50, and 75 percentile values for the environmental variables. The mean value for PM10 is 33 µg/m3.
|
Table 3 shows the results for the effect of PM10 by strata of diabetes and age. The results are expressed as the percentage increase in admissions for a 10µg/m3 increment of PM10.
|
These results show a clear effect modification due to diabetes in persons with CVD. The same effect modification was found when stratifying by age.
We did not find effect modification for COPD and pneumonia due to diabetes in all ages. When we analyzed by age, we found that diabetes is an effect modifier in younger persons with pneumonia, and in older persons for the risk of PM10-induced COPD.
| |
DISCUSSION |
|---|
|
|
|---|
PM10 has been associated with daily deaths and hospital admissions in numerous studies over the past decade (1, 2, 26, 27). Recently, a comprehensive study of the 90 largest cities in the United States found that no other air pollutant confounded the mortality association, and that no other air pollutant was associated with significantly increased risk (5). A similar result was found for hospital admissions (5). Although the evidence for an effect of airborne particles is overwhelming, to date there are only indications of possible mechanisms.
As noted in the introduction, both diabetes and airborne particles have been associated with decreased heart rate variability (10, 14), increased thrombotic risk factors (12, 15, 16), and increases in systemic markers of inflammation (13). These similarities indicate that particles and diabetes may affect some of the same pathways, and suggested the possibility of a synergistic effect.
We have found a significant interaction for hospital admissions for heart disease, with more than twice the risk in persons with diabetes than in persons without diabetes. The same result was found in both age groups. This increase is likely biased downward because of misclassification of some persons with diabetes into our nondiabetic pool. There is no guarantee that all discharge diagnoses for heart disease patients will include a mention of diabetes, although it may be associated with increased payments.
Our finding does not prove that the mechanisms mentioned above play a role in the particle-associated heart disease admissions, but it strengthens the case for that role. It does indicate that persons with diabetes are an important at-risk group. The lack of detailed medical information on subjects was a limitation of this study, and suggests more detailed studies are warranted. We believe the interaction of particle exposure with diabetes deserves more attention, perhaps by some focused panel studies of heart rate variability and air pollution in persons with diabetes. Diabetes is a highly prevalent chronic illness. Data from the Third National Health and Nutrition Examination Survey indicate that 5.1% of the U.S. population older than 20 yr of age have diagnosed diabetes and an additional 2.7% have undiagnosed diabetes (28). Hence the public health implications of this association are important.
Although some have speculated that the population at risk of dying due to particulate air pollution is composed of those who are at the edge of death, and likely to die within a few days in any case, recent studies that investigated that hypothesis have not found that to be the case (29). Hence, the susceptible population is not just the critically ill. The finding of enhanced susceptibility in persons with diabetes may partially explain those findings.
Moreover, recent studies have found that subjects with impaired glucose tolerance without type II diabetes also had reduced heart rate variability (15). This suggests the at-risk population may be even larger.
In contrast, we found only weak evidence that diabetes modified the risk of PM10-induced respiratory hospital admissions. Although diabetes modified the risk of PM10-induced COPD admissions in older people and the risk of pneumonia admissions in younger persons, those effects were smaller than for heart disease admissions, as well as inconsistent by age.
There are far fewer admissions for respiratory illness than for heart disease, and it could be that a larger study would have detected a significant association. However, the differences in effect we saw were small as well as having overlapping confidence intervals.
This suggests that the mechanism is more specific for cardiovascular illness and it could depend on age groups. Nevertheless, this certainly deserves further investigation.
| |
Footnotes |
|---|
Correspondence and requests for reprints should be addressed to Antonella Zanobetti, Department of Environmental Health, Environmental Epidemiology Program, Harvard School of Public Health, 665 Huntington Avenue, Boston, MA 02115. E-mail: azanob{at}sparc6a.harvard.edu
(Received in original form December 9, 2000 and in revised form April 25, 2001).
Acknowledgments:
Supported by NIEHS Grant ES07937.
| |
References |
|---|
|
|
|---|
1. Pope CA, Dockery DW, Schwartz J. Review of epidemiologic evidence of health effects of particulate air pollution. Inhal Toxicol 1995; 7: 1-18 .
2. Zanobetti A, Schwartz J, Dockery DW. Airborne particles are a risk factor for hospital admissions for heart and lung disease. Environ Health Perspect 2000; 108: 1071-1077 [Medline].
3. Schwartz J. Assessing confounding, effect modification, and thresholds in the association between ambient particles and daily deaths. Environ Health Perspect 2000; 108: 563-568 [Medline].
4. Schwartz J. Air pollution and hospital admissions for heart disease in eight US counties. Epidemiology 1999; 10: 17-22 [Medline].
5. Samet JM, Zegar SL, Dominici F, Curriero F, Coursac I, Dockery DW, Schwartz J, Zanobetti A. The National Morbidity, Mortality, and Air Pollution Study Part II: Morbidity, Mortality, and Air Pollution in the United States. Health Effects Inst 2000; 94: 1-84 .
6. Samet J, Zeger S, Kelsall J, Xu J, Kalkstein L. Does weather confound or modify the association of particulate air pollution with mortality? An analysis of the Philadelphia data, 1973-1980. Environ Res 1998; 77: 9-19 [Medline].
7. National Research Council. Research priorities for airborne particulate matter. Washington DC: National Academy Press; 1998.
8. Zanobetti A, Schwartz J. Race, gender, and social status as modifiers of the effects of PM10 on mortality. J Occup Environ Med 2000; 42: 469-474 [Medline].
9. Zanobetti A, Schwartz J, Gold DR. Are the sensitive subgroups for the health effects of airborne particles? Environ Health Perspect 2000; 108: 841-845 [Medline].
10.
Sunyer J,
Schwartz J,
Tobias A,
MacFarlane D,
Garcia J,
Anto JM.
Patients with chronic obstructive pulmonary disease are a susceptible
population of dying due to urban particles.
Am J Epidemiol
2000;
151:
50-56
11. Gold HRV, Gold DR, Litonjua A, Schwartz J, Lovett E, Larson A, Nearing B, Allen G, Verrier M, Cherry R, Verrier R. Ambient pollution and heart rate variability. Circulation 2000; 101: 1267-1273 [Medline].
12. Pope CA III,, Verrier RL, Lovett EG, Larson AC, Raizenne ME, Kanner RE, Schwartz J, Villegas GM, Dockery DW. Heart rate variability associated with particulate air pollution. Am Heart J 1999; 138: 890-899 [Medline].
13.
Peters A,
Frohlich M,
Doring A,
Immervoll T,
Wichmann H-E,
Hutchinson WL,
Pepsy MB,
Koenig W.
Particulate air pollution is associated with an acute phase response in men: results from the MONICA
Augsburg study.
Eur Heart J
2001;
22:
1198-1204
14.
Salvi S,
Blomberg A,
Rudell B,
Kelly F,
Sandstrom T,
Holgate ST,
Frew A.
Acute inflammatory responses in the airways and peripheral blood
after short-term exposure to diesel exhaust in healthy human volunteers.
Am J Respir Crit Care Med
1999;
159:
702-709
15. Schwartz J. Air pollution and blood markers of cardiovascular risk. Environ Health Perspect 2001;109(Suppl 3):405-409.
16. Singh JP, Larson MG, O'Donnell CJ, Wilson PF, Tsuji H, Lloyd-Jones DM, Levy D. Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study). Am J Cardiol 2000; 86: 309-312 [Medline].
17.
Stee JJ,
Silberhatz H,
Tofler GH,
Matheney TH,
Sutherland P,
Lipinska I,
Massaro JM,
Wilson PF,
Muller JE,
D'Agostino RB Sr..
Association
of fibrinogen with cardiovascular risk factors and cardiovascular disease in the Framingham Offspring Study.
Circulation
2000;
102:
1634-1638
18. Gerritsen J, Dekker JM, TenVoorde BJ, Bertelsmann FW, Kostense PJ, Stehouwer CD, Heine RJ, Nijpels G, Heethaar RM. Glucose tolerance and other determinants of cardiovascular autonomic function: the Hoorn Study. Diabetologia 2000; 43: 561-570 [Medline].
19. Nehls GJ, Akland GG. Procedures for handling aerometric data. J Air Pollution Control Assoc 1973; 23: 180-184 .
20. Hastie T, Tibshirani R. Generalized additive models. London: Chapman and Hall; 1990.
21.
Schwartz J.
Air pollution and daily mortality in Birmingham, Alabama.
Am J Epidemiol
1993;
137:
1136-1147
22. Schwartz J. Generalized additive models in epidemiology. International Biometric Society, Washington, DC. Invited Papers. 17th International Biometric Conference; 1994, p 55-80.
23. Norris G, YoungPong SN, Koenig JQ, Larson TV, Sheppard L, Stout JW. An association between fine particles and asthma emergency department visits for children in Seattle. Environ Health Perspect 1999; 107: 489-493 [Medline].
24. Akaike H. Information theory and an extension of the maximum likelihood principle. In: Petrov BN, Csaki F, editors. 2nd International symposium on information theory. Budapest: Akademiai Kaiado, 1973.
25. Brumback BA, Ryan LM, Schwartz J, Neas LM, Stark PC, Burge HA. Transitional regression models with application to environmental time series. JASA 2000; 95: 16-28 .
26.
Katsouyanni K,
Touloumi G,
Spix C,
Schwartz J,
Balducci F,
Medina S,
Rossi G,
Wojtyniak D,
Sunyer J,
Bacharova L,
Schouten JP,
Pontak A,
Anderson HR.
Short term effects of ambient sulphur dioxide and
particulate matter on mortality in 12 European cities: results from
time series data from the APHEA project.
Br Med J
1997;
314:
1658-1663
27. Schwartz J. Air pollution and hospital admissions for heart disease in eight U.S. counties. Epidemiology 1999; 10: 17-22 .
28. Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, Wiedmeyer HM, Byrd-Holt DD. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988- 1994. Diabetes Care 1998; 21: 518-524 [Abstract].
29. Zeger SL, Dominici F, Samet J. Harvesting-resistant estimates of air pollution effects on mortality. Epidemiology 1999; 10: 171-175 [Medline].
30.
Schwartz J.
Harvesting and long-term exposure effects in the relationship between air pollution and mortality.
Am J Epidemiol
2000;
151:
440-448
31. Zanobetti A, Wand MP, Schwartz J, Ryan L. Generalized additive distributed lag models: quantifying mortality displacement. Biostatistics 2000; 1: 279-292 .
This article has been cited by other articles:
![]() |
A. V. Diez Roux, A. H. Auchincloss, T. G. Franklin, T. Raghunathan, R. G. Barr, J. Kaufman, B. Astor, and J. Keeler Long-term Exposure to Ambient Particulate Matter and Prevalence of Subclinical Atherosclerosis in the Multi-Ethnic Study of Atherosclerosis Am. J. Epidemiol., March 15, 2008; 167(6): 667 - 675. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Peel, K. B. Metzger, M. Klein, W. D. Flanders, J. A. Mulholland, and P. E. Tolbert Ambient Air Pollution and Cardiovascular Emergency Department Visits in Potentially Sensitive Groups Am. J. Epidemiol., March 15, 2007; 165(6): 625 - 633. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Zeka, A. Zanobetti, and J. Schwartz Individual-Level Modifiers of the Effects of Particulate Matter on Daily Mortality Am. J. Epidemiol., May 1, 2006; 163(9): 849 - 859. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Proctor, K. L. Dreher, S. E. Kelly, and J. C. Russell Hypersensitivity of Prediabetic JCR:LA-cp Rats to Fine Airborne Combustion Particle-Induced Direct and Noradrenergic-Mediated Vascular Contraction Toxicol. Sci., April 1, 2006; 90(2): 385 - 391. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. O'Neill, A. Veves, A. Zanobetti, J. A. Sarnat, D. R. Gold, P. A. Economides, E. S. Horton, and J. Schwartz Diabetes Enhances Vulnerability to Particulate Air Pollution-Associated Impairment in Vascular Reactivity and Endothelial Function Circulation, June 7, 2005; 111(22): 2913 - 2920. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Boezen, J. M. Vonk, S. C. van der Zee, J. Gerritsen, G. Hoek, B. Brunekreef, J. P. Schouten, and D. S. Postma Susceptibility to air pollution in elderly males and females Eur. Respir. J., June 1, 2005; 25(6): 1018 - 1024. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. M Silva, N. Corson, A. Elder, and G. Oberdorster The Rat Ear Vein Model for Investigating In Vivo Thrombogenicity of Ultrafine Particles (UFP) Toxicol. Sci., June 1, 2005; 85(2): 983 - 989. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Wellenius, T. F. Bateson, M. A. Mittleman, and J. Schwartz Particulate Air Pollution and the Rate of Hospitalization for Congestive Heart Failure among Medicare Beneficiaries in Pittsburgh, Pennsylvania Am. J. Epidemiol., June 1, 2005; 161(11): 1030 - 1036. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Schwartz The effects of particulate air pollution on daily deaths: a multi-city case crossover analysis Occup. Environ. Med., December 1, 2004; 61(12): 956 - 961. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.E. Sharman, J.R. Cockcroft, and J.S. Coombes Cardiovascular implications of exposure to traffic air pollution during exercise QJM, October 1, 2004; 97(10): 637 - 643. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Brook, B. Franklin, W. Cascio, Y. Hong, G. Howard, M. Lipsett, R. Luepker, M. Mittleman, J. Samet, S. C. Smith Jr, et al. Air Pollution and Cardiovascular Disease: A Statement for Healthcare Professionals From the Expert Panel on Population and Prevention Science of the American Heart Association Circulation, June 1, 2004; 109(21): 2655 - 2671. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Schwartz Air Pollution and Children's Health Pediatrics, April 1, 2004; 113(4/S1): 1037 - 1043. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Kaminsky Spirometry and Diabetes: Implications of reduced lung function Diabetes Care, March 1, 2004; 27(3): 837 - 838. [Full Text] [PDF] |
||||
![]() |
M. R. Niefeld, J. B. Braunstein, A. W. Wu, C. D. Saudek, W. E. Weller, and G. F. Anderson Preventable Hospitalization Among Elderly Medicare Beneficiaries With Type 2 Diabetes Diabetes Care, May 1, 2003; 26(5): 1344 - 1349. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Philips and E. Baker Editorial III: Hyperglycaemia and the lung Br. J. Anaesth., April 1, 2003; 90(4): 430 - 433. [Full Text] [PDF] |
||||
![]() |
R. L. Verrier, M. A. Mittleman, and P. H. Stone Air Pollution: An Insidious and Pervasive Component of Cardiac Risk Circulation, August 20, 2002; 106(8): 890 - 892. [Full Text] [PDF] |
||||
![]() |
M. J. TOBIN Chronic Obstructive Pulmonary Disease, Pollution, Pulmonary Vascular Disease, Transplantation, Pleural Disease, and Lung Cancer in AJRCCM 2001 Am. J. Respir. Crit. Care Med., March 1, 2002; 165(5): 642 - 662. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Cell Mol. Biol. |